PEP44™

PEP 44 peptide demonstrated the ability to neutralize rapidly dividing cells

PEP44 is a biologically active intracellular peptide that acts as a highly precise biological switch, designed to regulate the cell cycle. It works inside cells to influence how they survive, divide, or die, shutting down the cellular pathways involved in complex biological processes.
About

PEP44™

PEP 44 demonstrated the ability to neutralize rapidly dividing cells while avoiding harm and preserving healthy cells.

PEP 44  demonstrated the activity in preclinical models in neutralizing rapidly dividing cells while avoiding harm and preserving healthy cells. This biologically active peptide interacts with internal pathways to influence cell survival, division, and death. 

Originating from cyclin D2, a protein key to cell cycle regulation, these intracellular peptides are now recognized as powerful signaling molecules capable of regulating essential processes.

PEP44 Explained

PEP44 enters the cell via a specialized carrier to disrupt duplication from within. It employs a multi-node strategy: simultaneously triggering a cell’s natural self-destruct sequence and stripping away its survival defenses. By attacking through these multiple biological pathways at once, PEP44 makes it significantly harder for targeted cells to develop resistance.

The Novel Science Behind

At the decision-making level, PEP44 rewires signaling networks by suppressing pro-survival Akt phosphorylation while activating stress kinases like p38 and the caspase pathways. This controlled approach induces regulated cell death, alters stress responses, and slows down the cell’s natural protein recycling process for precise results.

Clinically Validated Benefits

PEP19™ delivers measurable metabolic improvements through a targeted peripheral mechanism
Key Mechanics
Reduces Visceral Fat

Targets adipose tissue directly for measurable fat reduction
Key Mechanics
Improves Insulin Sensitivity
Targets adipose tissue directly for measurable fat reduction
Key Mechanics
Preserves Lean Mass

Maintains muscle tissue while reducing fat
Key Mechanics
Peripheral Mechanism

No CNS effects or behavioral modifications required

Future applications

Future applications may include:
Clinical Medicine & Therapeutics
  • nfections caused by multidrug-resistant (MDR) pathogens.
  • Candida: Tested against a number of Candida strains resistant to conventional treatments 
  • Skin Care: incorporated into topical treatments to promote re-epithelialization and angiogenesis 
  • Cancer Cell: focusing on solid, localized tumors it actively induces cell death in breast cancer and melanoma cells.
  • Medical Device Coatings: Applied to catheters, implants, and surgical materials to prevent bacterial adhesion and the formation of difficult-to-treat biofilms.
Doctors working together on digital tablet healthcare doctor tec

PEP44 Scientific Publications

This scientific research is supported by publications documenting a novel intracellular peptide derived from G1/S cyclin D2 that induces cell death, and Pep5-based peptides studied in oncology-related research with enhanced activity and synergistic effects, as also featured in the Journal of Biological Chemistry and ScienceDirect.
Pep5-Cpp, a Cyclin D2-Derived Antimicrobial Peptide…
Journal: Molecules (MDPI)
Year: 2026
Pep5-based antitumor peptides containing multifunctional fragments with enhanced activity and synergistic effect
Journal: European Journal of Medicinal Chemistry (Elsevier / ScienceDirect)
Year: 2022
Pep5, a Fragment of Cyclin D2, Shows Antiparasitic Effects…
Journal: Antimicrobial Agents and Chemotherapy (ASM Journals)
Year: 2019
(PDF – Semantic Scholar) A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells
Journal: Journal of Proteomics (Elsevier)
Year: 2017
A Novel Intracellular Peptide Derived from G1/S Cyclin D2 Induces Cell Death
Journal: Journal of Biological Chemistry
Year: 2014
Frequently Asked Questions

Scientific answers to common questions about us and our health platform

PEP44 is a biologically active peptide derived from cyclin D2, a protein that regulates the cell cycle. Once dismissed as biological waste, these intracellular peptides are now recognized as powerful signaling molecules that control essential life processes.
PEP44 enters cells via a specialized carrier to disrupt duplication from within. It re-wires signaling networks to trigger a natural self-destruct sequence while simultaneously stripping away the cell’s survival defenses.
Because PEP44 attacks multiple biological pathways at once—suppressing pro-survival signals while activating stress pathways—it is significantly harder for targeted cells to develop resistance compared to single-target treatments.
Preclinical testing has shown promising results across several fields. In oncology, it reduced aggressive brain tumor volume by nearly 50% in animal models. It also shows strong activity against resistant fungal species and has successfully extended the shelf life of crops like strawberries and roses in agricultural trials.

Partner with Us

Join us to revolutionize the use of bioactive peptides to  better lives worldwide. Our biotechnology advances peptide therapeutics through focused discovery, grounded in deep peptide expertise.

Our partners across pharma, food, biology, and beyond help drive the global market impact of novel peptide therapeutics.

Contact us

Get in touch

Headquarters

Proteimax Israel (HQ)
Proteimax Americas (US Office)
Proteimax Brazil (R&D Center)

Email

info@proteimax.com

This contact channel is reserved for potential corporate partnerships only. If you are a consumer with questions about PEP19, please reach out to your local territory distributor.

For USA inquiries, please contact